Literature DB >> 22436985

Stentless Versus Stented Bioprosthetic Aortic Valves: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2008.

John Pepper1, Davy Cheng, Rex Stanbridge, Francis D Ferdinand, W R Eric Jamieson, Paul Stelzer, Geoffrey Berg, Guido Sani, Janet Martin.   

Abstract

OBJECTIVE: : The purpose of this consensus conference was to determine whether stentless bioprosthetic valves improve clinical and resource outcomes compared with stented valves in patients undergoing aortic valve replacement, and to outline evidence-based recommendations for the use of stentless and stented bioprosthetic valves in adult aortic valve replacement.
METHODS: : Before the consensus conference, the best available evidence was reviewed in that systematic reviews, randomized trials, and nonrandomized trials were considered in descending order of validity and importance. At the consensus conference, evidence-based statements were created, and consensus processes were used to determine the ensuing recommendations. The American Heart Association/American College of Cardiology system was used to label the level of evidence and class of recommendation. RESULTS AND RECOMMENDATIONS: : Seventeen randomized studies published in 23 articles involving 1317 patients, and 14 nonrandomized trial published in 18 articles involving 2485 patients were included in the meta-analysis and consensus conference. All randomized trials inserted the stentless bioprosthetic valves in the subcoronary configuration. The consensus panel agreed upon the following statements and recommendations in patients undergoing aortic valve replacement:Because there were no randomized control trial comparing subcoronary stentless prosthetic valve and root replacement, the following recommendations are derived from expert opinion:

Entities:  

Year:  2009        PMID: 22436985     DOI: 10.1097/IMI.0b013e3181a34872

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  5 in total

1.  Aortic Valve Reoperation After Stentless Bioprosthesis: Short- and Long-Term Outcomes.

Authors:  Bo Yang; Himanshu J Patel; Elizabeth L Norton; Christina Debenedictus; Linda Farhat; Xiaoting Wu; Kevin He; Whitney E Hornsby; Donald S Likosky; G Michael Deeb
Journal:  Ann Thorac Surg       Date:  2018-04-03       Impact factor: 4.330

Review 2.  Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review.

Authors:  Reza Tavakoli; Pichoy Danial; Ahmed Hamid Oudjana; Peiman Jamshidi; Max Gassmann; Pascal Leprince; Guillaume Lebreton
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-01-10

3.  Hemodynamic behavior of stentless aortic valves in long term follow-up.

Authors:  Torsten Christ; Herko Grubitzsch; Benjamin Claus; Georg Heinze; Simon Dushe; Wolfgang Konertz
Journal:  J Cardiothorac Surg       Date:  2014-12-20       Impact factor: 1.637

4.  Early and mid-term haemodynamic performance and clinical outcomes of St. Jude Medical Trifecta™ valve.

Authors:  Renata Raimundo; Soraia Moreira; Francisca Saraiva; Rui J Cerqueira; Pedro Teixeira; Elson Salgueiro; André Lourenço; Mário J Amorim; Jorge Almeida; Paulo Pinho; Adelino F Leite-Moreira
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  Stentless aortic valve replacement in the young patient: long-term results.

Authors:  Torsten Christ; Herko Grubitzsch; Benjamin Claus; Wolfgang Konertz
Journal:  J Cardiothorac Surg       Date:  2013-04-08       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.